Local and Cell-intrinsic complement: The new player in cancer progression
Authors:
Open Access
- 24 June 2025
- journal article
- review article
- Published by Elsevier in Seminars in Immunology
- Vol. 79, 101976
Abstract
No abstract availableKeywords
This publication has 166 references indexed in Scilit:
- The Different Responsiveness of C3- and C5-deficient Murine BM Cells to Oxidative Stress Explains Why C3 Deficiency, in Contrast to C5 Deficiency, Correlates with Better Pharmacological Mobilization and Engraftment of Hematopoietic CellsStem Cell Reviews and Reports, 2024
- The complement system as a target in cancer immunotherapyEuropean Journal of Immunology, 2024
- Unlocking the Power of Complement-Dependent Cytotoxicity: Engineering Strategies for the Development of Potent Therapeutic Antibodies for Cancer TreatmentsBioDrugs, 2023
- The Noncanonical Role of Complement Factor H in Retinal Pigment Epithelium (RPE) Cells and Implications for Age-Related Macular Degeneration (AMD)2023
- Bioinformatics analysis of C3 in brain low-grade gliomas as potential therapeutic target and promoting immune cell infiltrationMedical Oncology, 2022
- Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancerCellular Oncology, 2021
- Complement anaphylatoxins as immune regulators in cancerCancer Medicine, 2014
- Granzyme B: A New Crossroad of Complement and Apoptosis2011
- C5a promotes migration, proliferation, and vessel formation in endothelial cellsInflammation Research, 2010
- Mouse Crry/p65 is a regulator of the alternative pathway of complement activationEuropean Journal of Immunology, 1993